Final results of the randomized phase II DeLOS-II trial: Induction chemotherapy (IC) followed by radiotherapy (R) vs. cetuximab (E) plus IC and R for functional larynx preservation in resectable laryngeal and hypopharyngeal cancer (LHSCC)

Autor:	Oliver Koelbl, Orlando Guntinas-Lichius, Michael Flentje, Christian Sittel, Frank Schreiber, Ursula Schroeder, C Rudack, Rudolf Hagen, Georg Maschmeyer, Andreas Dietz, V Schilling, Martin Westhofen, Ulrich Keilholz, Jens Peter Klussmann, Thomas Foerg, Thomas Lenarz, Gunnar Wichmann, Hans Juergen Welkoborsky, Swantje Held, Dirk Esser
Rok vydání:	2016
Předmět:	Cancer Research medicine.medical_specialty Cetuximab business.industry medicine.medical_treatment Urology Induction chemotherapy Hypopharyngeal cancer medicine.disease Radiation therapy Laryngectomy 03 medical and health sciences 0302 clinical medicine Oncology Larynx preservation 030220 oncology & carcinogenesis medicine Stage (cooking) 030223 otorhinolaryngology business medicine.drug
Zdroj:	Journal of Clinical Oncology. 34:6025-6025
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2016.34.15_suppl.6025
Popis:	6025Background: To evaluate the impact of E added throughout IC and R on the rate of two-year functional laryngectomy free survival (fLFS). Methods: Untreated patients (pts) with stage III/IV LHSCC...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::00c8a6790fe91a82ee873a47de7fce19 https://doi.org/10.1200/jco.2016.34.15_suppl.6025 Zobrazit plný text záznamu